Nevro Investor Relations Material
Latest events
Q3 2024
Nevro
Q4 2024
4 Mar, 2025
M&A Announcement
6 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nevro Corp
Access all reports
Nevro Corp. is a medical device company specializing in developing and commercializing solutions for the treatment of chronic pain. The company’s primary product is the Senza spinal cord stimulation (SCS) system, which utilizes proprietary high-frequency technology to manage pain without causing paresthesia. The company is headquartered in Redwood City, California, and its shares are listed on the NYSE.
Key slides for Nevro Corp
Q2 2024
Nevro Corp
Q3 2024
Nevro Corp
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
NVRO
Country
🇺🇸 United States